APA

Olanow C. W., Damier P., Goetz C. G., Mueller T., Nutt J., Rascol O., Serbanescu A., Deckers F. & Russ H. (20040909). Multicenter, open-label, trial of sarizotan in Parkinson disease patients with levodopa-induced dyskinesias (the SPLENDID Study). : Clinical neuropharmacology.

Chicago

Olanow C Warren, Damier Philippe, Goetz Christopher G, Mueller Thomas, Nutt John, Rascol Olivier, Serbanescu Alexandru, Deckers Frieda and Russ Hermann. 20040909. Multicenter, open-label, trial of sarizotan in Parkinson disease patients with levodopa-induced dyskinesias (the SPLENDID Study). : Clinical neuropharmacology.

Harvard

Olanow C. W., Damier P., Goetz C. G., Mueller T., Nutt J., Rascol O., Serbanescu A., Deckers F. and Russ H. (20040909). Multicenter, open-label, trial of sarizotan in Parkinson disease patients with levodopa-induced dyskinesias (the SPLENDID Study). : Clinical neuropharmacology.

MLA

Olanow C Warren, Damier Philippe, Goetz Christopher G, Mueller Thomas, Nutt John, Rascol Olivier, Serbanescu Alexandru, Deckers Frieda and Russ Hermann. Multicenter, open-label, trial of sarizotan in Parkinson disease patients with levodopa-induced dyskinesias (the SPLENDID Study). : Clinical neuropharmacology. 20040909.